Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Shah, Raj
PropertyValue
overview Professor, Family & Preventive Medicine and the Rush Alzheimer’s Disease Center Overview: My academic career interest is the design of team-based, collaborative science infrastructures that generate impactful knowledge through clinical trials and other discovery research. My overall goal is to develop dynamic and adaptive systems to conduct clinical trials with diverse communities for the maintenance of disability-free survival. I am also the Rush site principal investigator for the Chicago Area Patient-Centered Outcomes Research Network (CAPriCORN), a consortium of academic health systems and other partners working to develop, test and implement strategies to improve care for diverse residents in the Chicago region to improve health care quality, health outcomes and health equity. I am the Rush site principal investigator for the All of Us Research Program of the NIH’s Precision Medicine Initiative. I also am an Associate Director of the Institute for Translational Medicine (ITM) as Cluster Leader for the Network Capacity Cluster. In this NIH funded CTSA program, I oversee the work to streamline clinical research startup and achieve more rapid recruitment at multiple ITM academic institutions. I was a member of the Rush Institutional Review Board for almost 15 years and has served on various other research-focused committees and leadership roles at Rush including the Assistant Vice-Provost, Clinical Research, Rush University. I have been the overall principal investigator for two investigator initiated clinical trials and one SBIR clinical trial. I am on the international steering committee investigator for the recently completed ASPirin in Reducing Events in the Elderly (ASPREE now ASPREE-XT) clinical trial and for the recently funded PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults (PREVENTABLE) clinical trial. I have been the Rush site principal investigator for federally sponsored, foundation sponsored, and industry sponsored Alzheimer’s disease related (over 25) and other common age-related conditions such as COVID-19 along with being a Rush sub-investigator on many other clinical trials. My research manuscripts focus on non-neurological, modifiable factors associated with disability-free longevity in aging, novel clinical trial design and implementation, and health equity. I also was an editor of the book Community Health Equity: A Chicago Reader published by the University of Chicago Press in 2019. I also have provided support for ongoing longitudinal research and infrastructure projects on memory and aging, including the Chicago Health and Aging Project, the Rush Memory and Aging Project, the Rush Religious Orders Study, the Rush Minority Aging and Research Study, the Rush Alzheimer’s Disease Core Center, the Rush Alzheimer’s Disease Assistance Center, the Rush Center of Excellence on Disparities in HIV and Aging, and the Rush Memory Clinic Data and Specimen Repository. I have led education, community engagement and recruitment efforts of the Rush Alzheimer’s Disease Center, especially in communities under-represented in aging research. I am the co-Director of the Center for Community Health Equity, an initiative jointly led by Rush University Medical Center and DePaul University designed to reduce hardship and improve health outcomes in Chicago. I also have provided mentorship to diverse students interested in the health sciences at the high school, college, graduate and post-graduate levels, especially through two well-established summer internship program he co-designed with other faculty. I have been an Executive Committee member of the Rush Mentoring Program and have served as a thesis advisor in the Master of Science in Clinical Research of The Graduate College. I have served as faculty on federally funded institutional (T32) training grants and have been a co-mentor and/or advisor on federally funded career development (K series) grants. He has developed and taught curriculum for the Family Medicine Leadership Program and the Master of Science in Clinical Research at Rush. Education: BS, Northwestern University – Evanston, Illinois (Chemical Engineering) MD, University of Illinois at Chicago College of Medicine – Chicago, Illinois (Medicine) Residency, West Suburban Hospital & Medical Center – Oak Park, Illinois (Family Medicine) Fellowship, Rush University Medical Center – Chicago, Illinois (Geriatric Medicine) My ORCID is 0000-0001-9706-9730. My Scopus ID is 10046255700. My NIH COMMONS name is rshah1
One or more keywords matched the following items that are connected to Shah, Raj
Item TypeName
Concept Aspirin
Academic Article Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study.
Academic Article The aspirin in reducing events in the elderly trial: Statistical analysis plan.
Academic Article ASPREE-D: Aspirin for the prevention of depression in the elderly
Academic Article Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.
Academic Article Effect of Aspirin on Disability-free Survival in the Healthy Elderly.
Academic Article Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
Academic Article Quality of Life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors.
Academic Article Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study.
Academic Article Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
Academic Article No Modulation of the Effect of Aspirin by Body Weight in Healthy Older Men and Women.
Academic Article Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial.
Academic Article Effect of Aspirin on Cancer Incidence and Mortality in Older Adults.
Academic Article Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease.
Academic Article Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older Adults.
Academic Article Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial.
Academic Article Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free Survival.
Academic Article Similar mortality risk in incident cognitive impairment and dementia: Evidence from the ASPirin in Reducing Events in the Elderly (ASPREE) trial.
Academic Article The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly Study.
Academic Article Anticholinergic medication burden and cognitive function in participants of the ASPREE study.
Academic Article Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial.
Academic Article Prediction of disability-free survival in healthy older people.
Academic Article Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial.
Academic Article Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly - eXTension (ASPREE-XT) Observational Study.
Academic Article Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort Study.
Academic Article Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical Trial.
Academic Article Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial.
Search Criteria
  • Aspirin